ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

XRX XORTX Therapeutics Inc

4.80
0.00 (0.00%)
15 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
XORTX Therapeutics Inc CSE:XRX CSE Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.80 3.24 24.00 0 01:00:00

Xerox Posts $1 Million Profit Amid Job Cuts; Sees 1Q Below View

23/01/2009 1:27pm

Dow Jones News


XORTX Therapeutics (CSE:XRX)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more XORTX Therapeutics Charts.

Xerox Corp. (XRX) eked out a profit amid a hefty charge from its plan to cut 5% of the work force resulting from falling demand.

Shares were down 12% at $6.70 in recent premarket trading as the copy-machine and printer giant also projected first-quarter earnings of 16 cents a share to 20 cents a share. Analysts surveyed by Thomson Reuters projected 24 cents.

Meanwhile, Xerox reported net income of $1 million, down from $382 million, or 41 cents a share, a year earlier. Excluding the restructuring charge and an equipment write-off, earnings were 30 cents a share. In October, Xerox projected 34 to 36 cents, below analysts' then-expectations.

Revenue fell 11% to $4.37 billion, with nearly half the drop due to the stronger dollar. Analysts had most recently expected $4.71 billion.

Gross margin fell to 37.9% from 40.5% on increased costs.

Like most other businesses, Xerox is battling falling sales brought on by the recession. In the quarter, post-sale revenue - service, supplies and rentals - fell 8%. Equipment sales slid 15%.

Its stock is down 43% for the past year, mired at levels not seen since early this decade. But in November it ruled out a dividend cut and tapping capital markets "in the foreseeable future," crediting its "strong" financial position. Xexox added that business from repeat customers and cost cuts would help it weather the recession. The workforce reductions are aimed at saving $200 million this year in addition to boosting profit growth.

-By Mike Barris, Dow Jones Newswires; 201-938-5658; mike.barris@dowjones.com

Click here to go to Dow Jones NewsPlus, a web front page of today's most important business and market news, analysis and commentary. You can use this link on the day this article is published and the following day.

 
 

1 Year XORTX Therapeutics Chart

1 Year XORTX Therapeutics Chart

1 Month XORTX Therapeutics Chart

1 Month XORTX Therapeutics Chart

Your Recent History

Delayed Upgrade Clock